It has been demonstrated that CCL19 can inhibit angiogenesis in CRC by miR-206 upregulation which subsequently leads to negative regulation of the Met/ERK/Elk-1/HIF-1α/VEGF-A pathway [44]. The gene discussed is HIF1A; the disease is colorectal carcinoma.